Title: Relaxant effect of a water soluble carbon monoxide-releasing molecule (CORM-3) on spontaneously hypertensive rat aortas.
Journal: Cardiovascular drugs and therapy 20120801
Title: Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90.
Journal: Bioorganic & medicinal chemistry letters 20120701
Title: Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.
Journal: Critical care research and practice 20120101
Title: Signaling mechanisms of inhibition of phospholipase D activation by CHS-111 in formyl peptide-stimulated neutrophils.
Journal: Biochemical pharmacology 20110115
Title: Guanylate cyclase activators, cell volume changes and IOP reduction.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20110101
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: The mechanism of (R,R) ZX-5 on increasing NO release.
Journal: International journal of molecular sciences 20100101
Title: Neuroprotective effects of furopyrazole derivative of benzylindazole analogs on C2 ceramide-induced apoptosis in cultured cortical neurons.
Journal: Bioorganic & medicinal chemistry letters 20090615
Title: YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells.
Journal: Molecular pharmacology 20090101
Title: NO-independent, haem-dependent soluble guanylate cyclase stimulators.
Journal: Handbook of experimental pharmacology 20090101
Title: Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1.
Journal: Bioorganic & medicinal chemistry letters 20070901
Title: YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9.
Journal: The Journal of pharmacology and experimental therapeutics 20060101
Title: Characterization of nitrosoalkane binding and activation of soluble guanylate cyclase.
Journal: Biochemistry 20051213
Title: Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1.
Journal: The European journal of neuroscience 20050301
Title: Salutary properties of YC-1 in the cardiovascular and hematological systems.
Journal: Current medicinal chemistry. Cardiovascular and hematological agents 20041001
Title: Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule.
Journal: British journal of pharmacology 20040601
Title: Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?
Journal: Biochemistry 20040323
Title: The inhibitory mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: an in vitro and in vivo study.
Journal: Journal of pharmacological sciences 20040301
Title: YC-1 facilitates release of the proximal His residue in the NO and CO complexes of soluble guanylate cyclase.
Journal: The Journal of biological chemistry 20030328
Title: YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function.
Journal: Biochemical and biophysical research communications 20020308
Title: Prolonged exposure to YC-1 induces apoptosis in adrenomedullary endothelial and chromaffin cells through a cGMP-independent mechanism.
Journal: Neuropharmacology 20011201
